Frank Hrisomalos, MD
Retina Specialist · Indianapolis, INNPI 1003106824
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,882 of the $3,548 with a category attached, or 81.2%. 17 manufacturers reported payments, led by Onmark, Inc. at 37.1% of the total. 2025 is the largest year on record at $2,127, more than ten times the $141 reported in 2019.
Across 72 payments — averaging $49.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Onmark, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$500
- Genentech USA, Inc.$348
- Astellas Pharma US Inc$293
- US Oncology Corporate, Inc.$202
- Harrow Eye, LLC$148
- plus $741 from 11 others
What the payments were for
- Travel & lodging$66619%
- Food & beverage$2,88281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Onmark, Inc. | 9 | $1,315 |
| Regeneron Healthcare Solutions, Inc. | 26 | $500 |
| Genentech USA, Inc. | 6 | $348 |
| Astellas Pharma US Inc | 5 | $293 |
| US Oncology Corporate, Inc. | 1 | $202 |
| Harrow Eye, LLC | 3 | $148 |
| Alimera Sciences, Inc. | 3 | $130 |
| Apellis Pharmaceuticals, Inc. | 6 | $130 |
| Eyepoint US, Inc. | 1 | $102 |
| Alcon | 2 | $96 |
| Amgen | 1 | $91 |
| ANI Pharmaceuticals, Inc. | 3 | $67 |
| AbbVie | 2 | $30 |
| Coopervision Inc. | 1 | $26 |
| Rxsight Inc | 1 | $23 |
| Biotissue Holdings Inc. | 1 | $23 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,548 in reported general payments places this provider in the 75th percentile of 21 retina specialist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 211 | $7,660 |
| Ketorolac Tromethamine | 93 | $2,943 |
| Brimonidine Tartrate | 32 | $1,981 |
| Difluprednate | 19 | $1,429 |
| Atropine Sulfate | 12 | $817 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 69 | $794 |
| MoxifloxacinMoxifloxacin Hcl | 16 | $576 |
| Latanoprost | 45 | $455 |
| Dorzolamide Hcl | 34 | $423 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 43 | $333 |
| Timolol Maleate | 40 | $279 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Indianapolis
- Nicholas HrisomalosIndianapolis$274
- Ankur ShahCarmel$569K
- Raj MaturiCarmel$100K
- Ramana MoorthyCarmel$61K
- Milan ShahCarmel$35K
- Rodney BucherCarmel$30K
- Melih UstaogluTerre Haute$4K
- Howard LazarusNew Albany$3K
- Julia HudsonCarmel$3K
- Steven VirataLafayette$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.